Alpha Wave Global
Chris Dimitropoulos serves as the Managing Director for Biotechnology Investments at Alpha Wave Global, LP since March 2021. Previously, Chris was the CEO and Co-Founder of Inexos Therapeutics from January 2019 to March 2021, where responsibilities included the identification and negotiation of licenses for genetic medicines while overseeing key business functions. Prior experience includes roles as Portfolio Manager at J. Goldman & Co., L.P., and Millennium Partners, focusing on innovative companies and biotech investments, respectively. Chris began their career at Astor Group as a VP, guiding healthcare portfolio companies in business development and corporate strategy. Chris holds a Master of Science in Biotechnology from The Johns Hopkins University and a degree from the University of Illinois Urbana-Champaign.
This person is not in any teams
This person is not in any offices
Alpha Wave Global
2 followers
Alpha Wave Global is a global investment management company with three main verticals: private equity, private credit, and public markets. The objective of the private equity partnerships is to invest in best-in-class venture and growth stage companies and endeavors to be helpful, long-term partners to these exceptional founders and management teams; credit, which includes direct private lending to businesses looking for funding solutions; and public markets in an uncorrelated strategy. Alpha Wave has offices in New York, Miami, London, Monaco, Madrid, Abu Dhabi, Tel Aviv, Bangalore, and Sydney.